Cargando…

Preclinical Assessment of Low Doses of Cisplatin in the Management of Acute Promyelocytic Leukemia

Cis-diamminedichloroplatinum (II) (cisplatin) is the most widely used chemotherapeutic drug for various cancers, but its effectiveness is limited by tumor cell resistance and the severe side effects it causes. Since high level of cisplatin is cytotoxic to both cancer and normal cells, the goal of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasari, Shaloam R, Velma, Venkatramreddy, Yedjou, Clement G, Tchounwou, Paul B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758698/ https://www.ncbi.nlm.nih.gov/pubmed/26900603

Ejemplares similares

Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells
por: Velma, Venkatramreddy, et al.
Publicado: (2016)

Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
por: Dasari, Shaloam, et al.
Publicado: (2022)

Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
por: Yedjou, Clement, et al.
Publicado: (2009)

Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer
por: Dasari, Shaloam, et al.
Publicado: (2020)

Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells
por: Kumar, Sanjay, et al.
Publicado: (2015)

Preclinical Assessment of Vernonia amygdalina Leaf Extracts as DNA Damaging Anti-cancer Agent in the Management of Breast Cancer
por: Yedjou, Clement, et al.
Publicado: (2008)

Oxidative Stress and DNA Damage Induced by Chromium in Liver and Kidney of Goldfish, Carassius auratus
por: Velma, Venkatramreddy, et al.
Publicado: (2013)

Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
por: Tchounwou, Paul B, et al.
Publicado: (2021)

Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment
por: Yedjou, Clement G., et al.
Publicado: (2006)

DNA Damage, Cell Cycle Arrest, and Apoptosis Induction Caused by Lead in Human Leukemia Cells
por: Yedjou, Clement G., et al.
Publicado: (2015)

Management of Acute Promyelocytic Leukemia in the Elderly
por: Lo-Coco, Francesco, et al.
Publicado: (2013)

Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells
por: Kumar, Sanjay, et al.
Publicado: (2014)

Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia.
por: Sung, K. W., et al.
Publicado: (1997)

Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
por: Yedjou, Clement, et al.
Publicado: (2010)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Progress and criticalities in the management of acute promyelocytic leukemia
por: Lo-Coco, Francesco, et al.
Publicado: (2017)

Management of Acute Promyelocytic Leukemia at Extremes of Age
por: Kayser, Sabine, et al.
Publicado: (2023)

Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells
por: Rogers, Christian S, et al.
Publicado: (2014)

Basic Apoptotic Mechanisms of Lead Toxicity in Human Leukemia (Hl-60) Cells
por: Yedjou, Clement G., et al.
Publicado: (2010)

History of Acute Promyelocytic Leukemia
por: Sanz, Miguel A., et al.
Publicado: (2021)

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
por: Turcas, Cristina, et al.
Publicado: (2020)

N-Acetyl-L-Cysteine Affords Protection against Lead-Induced Cytotoxicity and Oxidative Stress in Human Liver Carcinoma (HepG(2)) Cells
por: Yedjou, Clement G., et al.
Publicado: (2007)

Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection
por: Shim, Kevin G, et al.
Publicado: (2022)

Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia
por: Yoo, Eun Sun
Publicado: (2011)

Management of elderly patients with acute promyelocytic leukemia: progress and problems
por: Lengfelder, Eva, et al.
Publicado: (2013)

Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)

Acute promyelocytic leukemia with unusual karyotype
por: Gowri, Mangala, et al.
Publicado: (2011)

Notch Signaling in Acute Promyelocytic Leukemia
por: Grieselhuber, Nicole R., et al.
Publicado: (2013)

Nephrotic syndrome in acute promyelocytic leukemia
por: Moradveisi, Borhan, et al.
Publicado: (2014)

Leptomeningeal Relapse of Acute Promyelocytic Leukemia
por: Hadid, Tarik, et al.
Publicado: (2014)

Acute Promyelocytic Leukemia: A Summary
por: Ryan, Meaghan M.
Publicado: (2018)

Advances in Pediatric Acute Promyelocytic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

Acute promyelocytic leukemia in super male
por: Roshan, Reshma, et al.
Publicado: (2022)

Acute Appendicitis Secondary to Acute Promyelocytic Leukemia
por: Rodriguez, Eduardo A., et al.
Publicado: (2015)

The significance of low PU.1 expression in patients with acute promyelocytic leukemia
por: Zhu, Xuehua, et al.
Publicado: (2012)

D-Glucose-Induced Cytotoxic, Genotoxic, and Apoptotic Effects on Human Breast Adenocarcinoma (MCF-7) Cells
por: Tchounwou, Christine K, et al.
Publicado: (2014)

Coilin participates in the suppression of RNA polymerase I in response to cisplatin-induced DNA damage
por: Gilder, Andrew S., et al.
Publicado: (2011)

Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation
por: Jillella, Anand P., et al.
Publicado: (2017)

Current views on the genetic landscape and management of variant acute promyelocytic leukemia
por: Zhang, Xiang, et al.
Publicado: (2021)

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
por: LaBella, Dominic, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o3keoo2jkbu8kbkjbpjrjiep9d